Skip to main content
. Author manuscript; available in PMC: 2023 Nov 20.
Published in final edited form as: Clin Pharmacokinet. 2023 Sep 21;62(11):1611–1619. doi: 10.1007/s40262-023-01307-6

Table 4.

UAR of infants (N = 200 per age group) breastfed by mothers during real-world use of CBD and CBD-containing products

Parameter > 0 to 7 days old > 7 to 14 days old > 14 to 30 days old > 30 to 60 days old > 60 to 365 days old

All concentrations
95th percentile of simulated breastfeeding infants AUC0τ (ng∙h/mL) 1.87 3.60 4.50 4.60 1.23
UARa 0.0024 0.0047 0.0058 0.0060 0.0016
Joint/blunt or edible exposure
95th percentile of simulated breastfeeding infants AUC0τ (ng∙h/mL) 0.22 0.40 0.69 0.50 0.25
UARa 0.00029 0.00047 0.00090 0.00065 0.00033
Oil or pipe exposure
95th percentile of simulated breastfeeding infants AUC0τ (ng∙h/mL) 3.23 35.25 17.09 4.56 4.00
UARa 0.0042 0.046 0.022 0.0059 0.0052

AUC area under the curve, CBD cannabidiol, UAR upper area under the curve ratio

a

UAR denominator consists of the simulated median AUC0τ based on the children aged 4–11 years from Devinsky et al. [13] receiving therapeutic doses for approved indications